Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preflucel Immunogenicity and Safety Study (2010/2011)
NCT01157702Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Jul 2010
- Primary completion
- Aug 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (vero cell-derived) in influenza, sponsored by Resilience Government Services. Started Jul 2010; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01157702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157702.